• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.

作者信息

Chung Jin Wook

机构信息

Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2018 Jun;24(2):135-136. doi: 10.3350/cmh.2018.1001. Epub 2018 Feb 22.

DOI:10.3350/cmh.2018.1001
PMID:29471609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6038938/
Abstract
摘要

相似文献

1
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.肝细胞癌伴门静脉侵犯患者手术切除与经动脉化疗栓塞联合额外放射治疗的比较
Clin Mol Hepatol. 2018 Jun;24(2):135-136. doi: 10.3350/cmh.2018.1001. Epub 2018 Feb 22.
2
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
3
Methods to improve resectability of hepatocellular carcinoma.
Recent Results Cancer Res. 2013;190:57-67. doi: 10.1007/978-3-642-16037-0_4.
4
Surgical Resection Versus Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question.中期肝细胞癌（BCLC-B期）的手术切除与经动脉化疗栓塞术：一个未解决的问题。
Hepatology. 2019 Feb;69(2):923. doi: 10.1002/hep.30338.
5
Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.可切除肝细胞癌的术前经动脉化疗栓塞术对术后患者预后有不利影响。
Aliment Pharmacol Ther. 2008 Feb 15;27(4):338-45. doi: 10.1111/j.1365-2036.2007.03580.x. Epub 2007 Nov 28.
6
Tumor compression-induced portal obstruction and selective transarterial chemoembolization increase functional liver volume in the unobstructed area, facilitating successful resection of a large HCC.肿瘤压迫所致门静脉阻塞和选择性经动脉化疗栓塞可增加未阻塞区域的功能性肝体积，有助于成功切除大肝癌。
Int Surg. 2013 Oct-Dec;98(4):388-91. doi: 10.9738/INTSURG-D-13-00013.1.
7
ASO Author Reflections: The Role of Postoperative Adjuvant Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Hepatic Vein Invasion.ASO作者反思：经动脉化疗栓塞术在肝细胞癌合并肝静脉侵犯患者术后辅助治疗中的作用
Ann Surg Oncol. 2019 Dec;26(Suppl 3):709-710. doi: 10.1245/s10434-019-07672-6. Epub 2019 Aug 29.
8
Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.序贯性经动脉化疗栓塞术与门静脉栓塞术治疗大肝细胞癌：文献系统综述
Minerva Chir. 2016 Jun;71(3):192-200. Epub 2016 Feb 17.
9
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.肝切除术与经动脉化疗栓塞术治疗伴有肝静脉瘤栓的肝细胞癌
Jpn J Clin Oncol. 2015 Sep;45(9):837-43. doi: 10.1093/jjco/hyv089. Epub 2015 Jun 15.
10
Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.经动脉重复化疗栓塞术治疗门静脉侵犯型肝细胞癌的再评估
J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x. Epub 2009 Jan 13.

本文引用的文献

1
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.比较手术切除与经动脉化疗栓塞联合额外放射治疗在伴有门静脉侵犯的肝细胞癌患者中的疗效。
Clin Mol Hepatol. 2018 Jun;24(2):144-150. doi: 10.3350/cmh.2017.0041. Epub 2018 Jan 16.
2
Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.肝切除术与经动脉化疗栓塞治疗合并门静脉癌栓的肝细胞癌的生存获益：系统评价和荟萃分析。
BMC Cancer. 2017 Dec 28;17(1):902. doi: 10.1186/s12885-017-3895-z.
3
Combined Cisplatin-Based Chemoembolization and Radiation Therapy for Hepatocellular Carcinoma Invading the Main Portal Vein.基于顺铂的联合化疗栓塞与放射治疗用于侵犯门静脉主干的肝细胞癌
J Vasc Interv Radiol. 2015 Aug;26(8):1130-8. doi: 10.1016/j.jvir.2015.05.006. Epub 2015 Jun 25.
4
Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.伴有门静脉癌栓的晚期肝细胞癌行化疗栓塞联合或不联合放射治疗及索拉非尼的比较：一项倾向评分分析
J Vasc Interv Radiol. 2015 Mar;26(3):320-9.e6. doi: 10.1016/j.jvir.2014.10.019. Epub 2015 Jan 19.
5
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.香港肝癌分期系统的建立与肝癌患者治疗分层策略。
Gastroenterology. 2014 Jun;146(7):1691-700.e3. doi: 10.1053/j.gastro.2014.02.032. Epub 2014 Feb 25.
6
Current strategy for staging and treatment: the BCLC update and future prospects.当前的分期和治疗策略：BCLC 更新及未来展望。
Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19.